Table 1.
Appraisals included in the analysis (n =196)
| Variable | STA | MTA |
|---|---|---|
| N | 80 | 116 |
| Guidance published* | 39 | 97 |
| Appraisal suspended* | 8 | 14 |
| Appraisal of a drug or drugs | 79 | 73 |
| Appraisal cancer-related | 47 | 29 |
| At least one appeal† | 9 | 36 |
| Review | 3 | 26 |
*At the time the analysis was undertaken.
†Appeals are made by consultees (often the producer of the technology) against final appraisal determinations, that is, NICE's provisional guidance.
MTA, Multiple Technology Appraisal; NICE, National Institute for Health and Clinical Excellence; STA, Single Technology Appraisal.